Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pharmagen Inc

PHRX
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US71715W1062
Sector Healthcare
Industry Medical Distribution
Exchange OTCCE
Capitalization 361 953 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
PHRX
21.11.2021 - 28.11.2021

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland. Address: 9337 Fraser Avenue, Silver Spring, MD, United States, 20910

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.13 USD

P/E ratio

Dividend Yield

Current Year

+4 813 048 USD

Last Year

+4 260 610 USD

Current Quarter

+1 319 464 USD

Last Quarter

+1 043 062 USD

Current Year

+3 045 212 USD

Last Year

+1 264 504 USD

Current Quarter

+736 474 USD

Last Quarter

+641 693 USD

Key Figures PHRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -2 131 189 USD
Operating Margin TTM -31.11 %
PE Ratio
Return On Assets TTM -58.91 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 0.13 USD
Revenue TTM 4 411 181 USD
Book Value -0.016 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -23.3 %
Dividend Yield
Gross Profit TTM 3 045 212 USD
Earnings per share
Diluted Eps TTM
Most Recent Quarter I 2014
Quarterly Earnings Growth YOY
Profit Margin -133.1 %

Dividend Analytics PHRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PHRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 45:1
Payout Ratio
Last Split Date 07.12.2011
Dividend Date

Stock Valuation PHRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.3452
Price Sales TTM 0.0821
Enterprise Value EBITDA -2.1602
Price Book MRQ

Financials PHRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PHRX

For 52 weeks

0.0001 USD 0.0001 USD
50 Day MA 0.0001 USD
Shares Short Prior Month
200 Day MA 0.0001 USD
Short Ratio
Shares Short
Short Percent